Publication of the first Japanese clinical study on SpineGuard’s DSG® technology

PARIS & BOULDER, Colo.–(BUSINESS WIRE)–Regulatory news:

SpineGuard (Paris:ALSGD) (FR0011464452 – ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance) detection technology to secure and streamline the placement of bone implants, today announces the first clinical study in Japan quantifying the performance of the DSG, 19and worldwide peer-reviewed publication on its technology.

Keri George, Director of Clinical Research and Education at SpineGuard, said: “It’s exciting to see Japanese surgeons adopting innovative DSG technology to achieve better surgical results in such difficult spinal deformity cases.”

Summary of the study

A retrospective collection by Dr. Takashi Yurube from the Department of Orthopedic Surgery, Kobe University et al, which involved twenty-one patients with syndromic/neuromuscular scoliosis. Patients who underwent spinal fixation surgery were divided into two groups, one had fixation using SpineGuard DSG technology; the other without it.

The results between the two groups showed a statistically significant difference on the three objectives: abandonment of the pedicle, precision of screw placement and perforation distance. In all three objectives, the DSG group showed superior results.


“Improving the accuracy and safety of pedicle screw placement using a probe with an electrical conductivity measuring device during spine surgery for severe syndromic and neuromuscular scoliosis”

Journal of Clinical Medicine

About SpineGuard®

Founded in 2009 in France and the United States by Pierre Jérôme and Stéphane Bette, SpineGuard is an innovative company that deploys its proprietary DSG® (Dynamic Surgical Guidance) radiation-free real-time detection technology to secure and streamline the placement of implants. in the skeleton. SpineGuard designs, develops and markets medical devices that have been used in more than 85,000 surgeries worldwide. Nineteen studies published in peer-reviewed scientific journals have demonstrated the multiple benefits that DSG® offers to patients, surgeons, surgical staff and hospitals. Building on these solid fundamentals and several strategic partnerships, SpineGuard has expanded the scope of its DSG® technology into innovative applications such as the “intelligent” pedicle screw, the DSG Connect visualization and registration interface, dental implantology and surgical robotics. DSG® was co-invented by Maurice Bourlion, Ph.D., Ciaran Bolger, MD, Ph.D., and Alain Vanquaethem, biomedical engineer. SpineGuard has engaged in multiple ESG initiatives.

For more information visit


SpineGuard securities may not be offered or sold in the United States because they have not been and will not be registered under the Securities Act or any United States securities law, and SpineGuard does not intend to make a public offer of its securities in the United States. United States. This is an announcement and not a prospectus, and the information contained herein does not constitute an offer to sell or the solicitation of an offer to buy, and there will be no sale of the securities. referred to herein in the United States where such offer, solicitation or sale would be unlawful prior to registration or exemption from registration.

Jacob L. Thornton